Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Collaborative Health Research Projects

École Polytechnique de Montréal

$182,740.00

Improving the identification of retinal biomarkers of Alzheimer disease in vivo

EF 2019-20

Résumé
Alzheimers disease is a slowly evolving neurodegenerative disorder that ultimately leading todementia. It is the most common cause of dementia, affecting millions worldwide, with no cureavailable at this time. One of the main issues with developing new therapies is the fact thatAlzheimer is usually diagnosed based on cognitive impairments, a diagnosis made late in theevolution of the disease. This proposal aims to develop a non-invasive detection toolexploiting commonalities between Alzheimer biomarkers present both in the brain and theeye. Our main goal is to identify signs of the disease earlier using a test that could be doneroutinely during an ophthalmology examination. We will develop methods combiningmultispectral retinal imaging with image processing to identify biomarkers of amyloid plaqueaccumulation in the retina and correlate results with brain PET amyloid imaging.
Programme
Collaborative Health Research Projects
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
523599-2018
Name nom
Lesage, Frederic
Department département
Génie Biomédical, Institut de
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2018
Award amount
182740
Program id
CHRPJ
Program name en
Collaborative Health Research Projects
Program name fr
Projets de recherche concertée sur la santé
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
360
Committee name en
Collaborative Health Research Projects Selection Panel
Committee name fr
Comité de sélection de projets de recherche concertée sur la santé
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical technology
Research subject fr
Technologie biomédicale
Installment
inst:2 - 3
Partie
2
Nb partie
3
Application title
Improving the identification of retinal biomarkers of Alzheimer disease in vivo
Keyword
NSERC
Application summary
Alzheimers disease is a slowly evolving neurodegenerative disorder that ultimately leading todementia. It is the most common cause of dementia, affecting millions worldwide, with no cureavailable at this time. One of the main issues with developing new therapies is the fact thatAlzheimer is usually diagnosed based on cognitive impairments, a diagnosis made late in theevolution of the disease. This proposal aims to develop a non-invasive detection toolexploiting commonalities between Alzheimer biomarkers present both in the brain and theeye. Our main goal is to identify signs of the disease earlier using a test that could be doneroutinely during an ophthalmology examination. We will develop methods combiningmultispectral retinal imaging with image processing to identify biomarkers of amyloid plaqueaccumulation in the retina and correlate results with brain PET amyloid imaging.